Skip to main content
. 2012 May 25;7(5):e38129. doi: 10.1371/journal.pone.0038129

Figure 5. Pro-apoptotic and anti-angiogenic activity of GD2 targeted nanoparticles containing miR-34a.

Figure 5

Tumors of mice treated with anti-GD2-miR-34a-NPs and negative controls were analyzed by TUNEL staining on paraffin embedded section of SK-N-ASluc (a) and NB1691luc (b) tumors. In both tumor subtypes, treatment with anti-GD2-miR34a-NPs led to a significant increase in apoptosis (c, ***p<0.001, n=8). Immunohistochemistry staining with CD34 showed a marked decrease in the endothelial cell marker subsequent to anti-GD2-miR34a-NP treatment (d-f, ***p<0.001, n=8). KI67 staining showed reduced proliferation in anti-GD2-miR34a-NP treated cohorts (g-i, ***p<0.001, n=8).